Compound Information
Test on : RBC, Metz
Compound Name
RBC, Metz : VX-702
Inchikey
Same : FYSRKRZDBHOFAY-N
RBC, Metz : FYSRKRZDBHOFAY-UHFFFAOYSA-N
ChemSpider
RBC, Metz : 8516613
Pubchem CID
RBC, Metz : 10341154
ChEMBL
RBC, Metz : CHEMBL1090090
|
DRx |
RBC |
Metz |
Millipore |
GPCR |
bioactivity |
Kd (nM) |
Remain Activity (%) |
Ki (nM) |
Remain Activity (%) |
Inhibition (%) |
active criteria |
<3000nM |
<50% |
<1000nM |
<50% |
>50% |
AGC
AGC - PDK1
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PDK1 | inactive (87.4%) | - |
AGC - Akt
Bioactivity |
---|
Kinase | RBC | Metz |
---|
AKT1 | inactive (84.72%) | - |
AKT2 | inactive (118.28%) | - |
AKT3 | inactive (86.24%) | - |
AGC - DMPK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
DMPK1 | inactive (103.72%) | - |
MRCKa | inactive (93.8%) | - |
MRCKb | inactive (96.52%) | - |
ROCK1 | inactive (107.81%) | inactive (2511.89nM) |
ROCK2 | inactive (97.66%) | - |
AGC - GRK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
BARK1 | inactive (99.03%) | - |
BARK2 | inactive (98.14%) | - |
GPRK4 | inactive (90.74%) | - |
GPRK5 | inactive (103.21%) | - |
GPRK6 | inactive (97.05%) | - |
GPRK7 | inactive (108.5%) | - |
AGC - RSK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
MSK1 | inactive (92.85%) | - |
MSK2 | inactive (99.01%) | - |
p70S6K | inactive (100.13%) | - |
p70S6Kb | inactive (100.08%) | - |
RSK2 | inactive (99.84%) | - |
RSK4 | inactive (101.25%) | - |
RSK1 | inactive (108.84%) | - |
RSK3 | inactive (97.53%) | - |
AGC - PKA
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PKACg | inactive (109.18%) | - |
PRKX | inactive (123.07%) | - |
PKACa | inactive (100.84%) | - |
AGC - PKC
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PKCa | inactive (85.96%) | - |
PKCd | inactive (103.55%) | - |
PKCe | inactive (100.78%) | - |
PKCh | inactive (112.44%) | - |
PKCg | inactive (91.25%) | - |
PKCi | inactive (99.14%) | - |
PKCt | inactive (85.11%) | - |
PKCz | inactive (89.94%) | - |
PKCb | inactive (94.64%) | - |
AGC - PKG
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PKG2 | inactive (98.09%) | - |
PKG1 | inactive (88.06%) | - |
AGC - PKN
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PKN1 | inactive (101.2%) | - |
PKN2 | inactive (99.71%) | - |
AGC - SGK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
SGK1 | inactive (121.07%) | - |
SGK2 | inactive (106.76%) | - |
SGK3 | inactive (99.92%) | - |
AGC - NDR
Bioactivity |
---|
Kinase | RBC | Metz |
---|
NDR1 | inactive (101.19%) | - |
TK
TK - Abl
Bioactivity |
---|
Kinase | RBC | Metz |
---|
ABL1 | inactive (99.67%) | - |
ABL2 | inactive (100%) | - |
TK - Ack
Bioactivity |
---|
Kinase | RBC | Metz |
---|
ACK | inactive (96.1%) | - |
TK - ALK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
ALK | inactive (99.57%) | - |
LTK | inactive (95.02%) | - |
TK - Axl
Bioactivity |
---|
Kinase | RBC | Metz |
---|
AXL | inactive (100.77%) | - |
MER | inactive (113.77%) | - |
TYRO3 | inactive (100.71%) | - |
TK - Src
Bioactivity |
---|
Kinase | RBC | Metz |
---|
BLK | inactive (100.05%) | - |
BRK | inactive (98.72%) | - |
SRC | inactive (108.84%) | - |
FGR | inactive (94.73%) | - |
FRK | inactive (105.78%) | - |
FYN | inactive (110.36%) | - |
HCK | inactive (89.54%) | - |
LCK | inactive (86.3%) | - |
SRM | inactive (92.93%) | - |
YES | inactive (97.77%) | - |
LYN | inactive (98.14%) | - |
TK - Tec
Bioactivity |
---|
Kinase | RBC | Metz |
---|
BMX | inactive (107.75%) | - |
BTK | inactive (98.23%) | - |
ITK | inactive (104.65%) | - |
TEC | inactive (114.21%) | - |
TXK | inactive (103.69%) | - |
TK - PDGFR
Bioactivity |
---|
Kinase | RBC | Metz |
---|
KIT | inactive (97.69%) | - |
FLT3 | inactive (97.21%) | - |
FMS | inactive (109.14%) | - |
PDGFRb | inactive (62.76%) | - |
PDGFRa | inactive (101.99%) | - |
TK - Csk
Bioactivity |
---|
Kinase | RBC | Metz |
---|
CSK | inactive (89.97%) | - |
CTK | inactive (77.59%) | - |
TK - DDR
Bioactivity |
---|
Kinase | RBC | Metz |
---|
DDR2 | inactive (100.26%) | - |
TK - EGFR
Bioactivity |
---|
Kinase | RBC | Metz |
---|
EGFR | inactive (92.73%) | - |
ErbB2 | inactive (105.56%) | - |
ErbB4 | inactive (98.1%) | - |
TK - Eph
Bioactivity |
---|
Kinase | RBC | Metz |
---|
EphA1 | inactive (99.07%) | - |
EphA2 | inactive (88.97%) | - |
EphA3 | inactive (96.97%) | - |
EphA4 | inactive (104.93%) | - |
EphA5 | inactive (104.56%) | - |
EphA6 | inactive (95%) | - |
EphA7 | inactive (79.9%) | - |
EphA8 | inactive (98.66%) | - |
EphB1 | inactive (100.14%) | - |
EphB2 | inactive (106.73%) | - |
EphB3 | inactive (65.77%) | - |
EphB4 | inactive (83.88%) | - |
TK - FAK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
FAK | inactive (98.9%) | - |
PYK2 | inactive (101.68%) | - |
TK - Fer
Bioactivity |
---|
Kinase | RBC | Metz |
---|
FER | inactive (95.56%) | - |
FES | inactive (99.03%) | - |
TK - FGFR
Bioactivity |
---|
Kinase | RBC | Metz |
---|
FGFR1 | inactive (99.02%) | - |
FGFR2 | inactive (99.51%) | - |
FGFR3 | inactive (90.17%) | - |
FGFR4 | inactive (96.18%) | - |
TK - VEGFR
Bioactivity |
---|
Kinase | RBC | Metz |
---|
FLT1 | inactive (101.87%) | - |
FLT4 | inactive (97.5%) | - |
KDR | inactive (96.55%) | - |
TK - InsR
Bioactivity |
---|
Kinase | RBC | Metz |
---|
IGF1R | inactive (92.33%) | - |
IRR | inactive (102.41%) | - |
INSR | inactive (104.4%) | - |
TK - JakA
Bioactivity |
---|
Kinase | RBC | Metz |
---|
JAK1 | inactive (98.82%) | - |
JAK2 | inactive (106.83%) | - |
JAK3 | inactive (95.72%) | - |
TYK2 | inactive (93.46%) | - |
TK - Musk
Bioactivity |
---|
Kinase | RBC | Metz |
---|
MUSK | inactive (101.9%) | - |
TK - Ret
Bioactivity |
---|
Kinase | RBC | Metz |
---|
RET | inactive (93.12%) | - |
TK - Met
Bioactivity |
---|
Kinase | RBC | Metz |
---|
RON | inactive (90.13%) | - |
MET | inactive (89.43%) | - |
TK - Sev
Bioactivity |
---|
Kinase | RBC | Metz |
---|
ROS | inactive (95.02%) | - |
TK - Syk
Bioactivity |
---|
Kinase | RBC | Metz |
---|
SYK | inactive (109.95%) | - |
ZAP70 | inactive (100.12%) | - |
TK - Tie
Bioactivity |
---|
Kinase | RBC | Metz |
---|
TIE2 | inactive (96.73%) | - |
TK - Trk
Bioactivity |
---|
Kinase | RBC | Metz |
---|
TRKA | inactive (96.26%) | - |
TRKB | inactive (101.7%) | - |
TRKC | inactive (95.87%) | - |
TKL
TKL - STKR
Bioactivity |
---|
Kinase | RBC | Metz |
---|
ALK1 | inactive (99.29%) | - |
ALK2 | inactive (105.05%) | - |
ALK4 | inactive (113.39%) | - |
TGFbR1 | inactive (96.69%) | - |
TGFbR2 | inactive (102.17%) | - |
TKL - RAF
Bioactivity |
---|
Kinase | RBC | Metz |
---|
ARAF | inactive (99.36%) | - |
BRAF | inactive (94.06%) | - |
RAF1 | inactive (97.53%) | - |
TKL - IRAK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
IRAK1 | inactive (94.2%) | - |
IRAK4 | inactive (87.52%) | - |
TKL - LISK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
LIMK1 | inactive (98.51%) | - |
TKL - LRRK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
LRRK2 | inactive (82.03%) | - |
TKL - MLK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
MLK1 | inactive (112.25%) | - |
MLK2 | inactive (104.16%) | - |
MLK3 | inactive (104.89%) | - |
TAK1 | inactive (104.72%) | - |
ZAK | inactive (97.93%) | - |
TKL - RIPK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
RIPK2 | inactive (101.09%) | - |
CAMK
CAMK - CAMKL
Bioactivity |
---|
Kinase | RBC | Metz |
---|
NuaK1 | inactive (108.41%) | - |
BRSK1 | inactive (94.15%) | - |
BRSK2 | inactive (96.55%) | - |
CHK1 | inactive (89.17%) | - |
LKB1 | inactive (99.46%) | - |
MARK1 | inactive (131.85%) | - |
MARK3 | inactive (98.14%) | - |
MARK4 | inactive (102.26%) | - |
MELK | inactive (87.15%) | - |
PASK | inactive (103.04%) | - |
QIK | inactive (95.11%) | - |
NuaK2 | inactive (98.72%) | - |
MARK2 | inactive (130.96%) | - |
AMPKa1 | - | - |
CAMK - CAMK1
Bioactivity |
---|
Kinase | RBC | Metz |
---|
CaMK1a | inactive (98.11%) | - |
CaMK1b | inactive (108.06%) | - |
CaMK1d | inactive (113.75%) | - |
CaMK1g | inactive (108.33%) | - |
CaMK4 | inactive (91.87%) | - |
CAMK - CAMK2
Bioactivity |
---|
Kinase | RBC | Metz |
---|
CaMK2a | inactive (90.95%) | - |
CaMK2b | inactive (104.27%) | - |
CaMK2d | inactive (87.25%) | - |
CaMK2g | inactive (105.43%) | - |
CAMK - RAD53
Bioactivity |
---|
Kinase | RBC | Metz |
---|
CHK2 | inactive (97.64%) | - |
CAMK - DAPK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
DAPK1 | inactive (98.16%) | - |
DAPK2 | inactive (86.77%) | - |
DRAK1 | inactive (100.17%) | - |
DAPK3 | inactive (107.03%) | - |
CAMK - DCAMKL
Bioactivity |
---|
Kinase | RBC | Metz |
---|
DCLK2 | inactive (97.48%) | - |
DCLK1 | - | - |
CAMK - MAPKAPK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
MAPKAPK2 | inactive (98.9%) | - |
MAPKAPK3 | inactive (99.05%) | - |
MAPKAPK5 | inactive (93.38%) | - |
MNK1 | inactive (91.43%) | - |
MNK2 | inactive (100.81%) | - |
CAMK - MLCK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
smMLCK | inactive (101.08%) | - |
skMLCK | inactive (100.8%) | - |
CAMK - PHK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PHKg1 | inactive (92.04%) | - |
PHKg2 | inactive (93.14%) | - |
CAMK - PIM
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PIM1 | inactive (98.77%) | - |
PIM2 | inactive (98.3%) | - |
PIM3 | inactive (97.66%) | - |
CAMK - PKD
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PKD1 | inactive (97.75%) | - |
PKD3 | inactive (85.1%) | inactive (2511.89nM) |
PKD2 | inactive (81.84%) | inactive (5011.87nM) |
CAMK - TSSK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
TSSK1 | inactive (83.02%) | - |
TSSK2 | inactive (88.59%) | - |
CAMK - STK33
Bioactivity |
---|
Kinase | RBC | Metz |
---|
STK33 | inactive (93.97%) | - |
STE
STE - STE11
Bioactivity |
---|
Kinase | RBC | Metz |
---|
MAP3K5 | inactive (101.84%) | - |
MAP3K2 | inactive (121.52%) | - |
MAP3K3 | inactive (118.17%) | - |
STE - STE-Unique
Bioactivity |
---|
Kinase | RBC | Metz |
---|
COT | inactive (94.3%) | - |
NIK | inactive (113.96%) | - |
STE - STE20
Bioactivity |
---|
Kinase | RBC | Metz |
---|
GCK | inactive (107.96%) | - |
HGK | inactive (108.19%) | - |
KHS1 | inactive (98.26%) | - |
LOK | inactive (93.79%) | - |
MINK | inactive (100.39%) | - |
MST1 | inactive (100.52%) | - |
MST2 | inactive (94.08%) | - |
MST3 | inactive (105.33%) | - |
MST4 | inactive (117.24%) | - |
OSR1 | inactive (96.88%) | - |
PAK1 | inactive (110.38%) | - |
PAK2 | inactive (100.87%) | - |
PAK3 | inactive (98.29%) | - |
PAK4 | inactive (92.62%) | - |
PAK5 | inactive (96.35%) | - |
PAK6 | inactive (103.29%) | - |
SLK | inactive (90.75%) | - |
YSK1 | inactive (97.08%) | - |
STLK3 | inactive (93.66%) | - |
TAO1 | inactive (96.24%) | - |
TAO2 | inactive (98.74%) | - |
TAO3 | inactive (95.74%) | - |
MYO3B | inactive (99.25%) | - |
STE - STE7
Bioactivity |
---|
Kinase | RBC | Metz |
---|
MAP2K1 | inactive (88.98%) | - |
MAP2K2 | inactive (92.35%) | - |
MAP2K6 | inactive (96.54%) | - |
Other
Other - Aur
Bioactivity |
---|
Kinase | RBC | Metz |
---|
AurA | inactive (86.43%) | - |
AurB | inactive (91.27%) | - |
AurC | inactive (83.76%) | - |
Other - CAMKK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
CaMKK1 | inactive (98.9%) | - |
CaMKK2 | inactive (101.19%) | - |
Other - Haspin
Bioactivity |
---|
Kinase | RBC | Metz |
---|
Haspin | inactive (81.27%) | - |
Other - IKK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
IKKa | inactive (100.37%) | - |
IKKb | inactive (94.85%) | - |
IKKe | inactive (87.96%) | - |
TBK1 | inactive (106.41%) | - |
Other - NEK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
NEK1 | inactive (69.61%) | - |
NEK11 | inactive (92.86%) | - |
NEK2 | inactive (108.75%) | - |
NEK4 | inactive (103.56%) | - |
NEK6 | inactive (90.48%) | - |
NEK7 | inactive (90.11%) | - |
NEK9 | inactive (104.44%) | - |
NEK3 | inactive (96%) | - |
Other - TOPK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PBK | inactive (110.3%) | - |
Other - PLK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PLK1 | inactive (95.11%) | - |
PLK2 | inactive (101.68%) | - |
PLK3 | inactive (94.67%) | - |
PLK4 | - | - |
Other - SgK496
Bioactivity |
---|
Kinase | RBC | Metz |
---|
SgK496 | inactive (100.68%) | - |
Other - NAK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
MPSK1 | inactive (100.23%) | - |
Other - TTK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
TTK | inactive (98.77%) | - |
Other - ULK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
ULK1 | inactive (103.57%) | - |
ULK2 | inactive (100.83%) | - |
ULK3 | inactive (101.14%) | - |
Other - WEE
Bioactivity |
---|
Kinase | RBC | Metz |
---|
Wee1 | inactive (100.97%) | - |
Other - WNK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
Wnk2 | inactive (96.42%) | - |
Wnk3 | inactive (96.63%) | - |
Other - TLK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
TLK2 | inactive (95.75%) | - |
Other - CDC7
Bioactivity |
---|
Kinase | RBC | Metz |
---|
CDC7 | - | - |
CK1
CK1
Test Member No. in Family |
---|
Family | no. Member on 518kinase | RBC | Metz |
---|
CK1 | 7 | 6 | 5 |
VRK | 3 | 1 | - |
CK1 - CK1
Bioactivity |
---|
Kinase | RBC | Metz |
---|
CK1d | inactive (89.8%) | - |
CK1g1 | inactive (102.38%) | - |
CK1g2 | inactive (99.64%) | - |
CK1g3 | inactive (103.46%) | - |
CK1a | active (0%) | - |
CK1e | inactive (98.19%) | - |
CK1 - VRK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
VRK1 | inactive (104.3%) | - |
CMGC
CMGC - CK2
Bioactivity |
---|
Kinase | RBC | Metz |
---|
CK2a1 | inactive (110.95%) | - |
CK2a2 | inactive (108.53%) | - |
CMGC - CLK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
CLK1 | inactive (107.64%) | - |
CLK2 | inactive (86.92%) | - |
CLK3 | inactive (112.37%) | - |
CLK4 | inactive (113.91%) | - |
CMGC - DYRK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
DYRK1A | inactive (98.74%) | - |
DYRK1B | inactive (97.05%) | - |
DYRK2 | inactive (101.75%) | - |
DYRK3 | inactive (104.54%) | - |
DYRK4 | inactive (96.26%) | - |
HIPK1 | inactive (100.14%) | - |
HIPK2 | inactive (100.41%) | - |
HIPK3 | inactive (98.4%) | - |
HIPK4 | inactive (90.47%) | - |
CMGC - MAPK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
Erk1 | inactive (95.22%) | - |
Erk2 | inactive (85.72%) | - |
JNK3 | inactive (98.43%) | - |
NLK | active (15.78%) | - |
p38a | active (5.23%) | - |
p38b | active (22.32%) | - |
p38d | inactive (93.95%) | - |
p38g | inactive (92.09%) | - |
JNK1 | inactive (100.35%) | - |
JNK2 | inactive (93.53%) | - |
CMGC - GSK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
GSK3A | inactive (98.56%) | - |
GSK3B | inactive (101.43%) | - |
CMGC - SRPK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
MSSK1 | inactive (105.01%) | - |
SRPK1 | inactive (98.96%) | - |
SRPK2 | - | - |
CMGC - CDK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
CDC2 | - | - |
CDK2 | - | - |
CDK5 | - | - |
CDK8 | - | - |
CDK7 | - | - |
CDK9 | - | - |
CDK11 | - | - |
Atypical
Atypical
Test Member No. in Family |
---|
Family | no. Member on 518kinase | RBC | Metz |
---|
PDHK | 5 | 1 | - |
Alpha | 6 | - | 1 |
Atypical - PDHK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PDHK1 | inactive (87.4%) | - |
Atypical - Alpha
Bioactivity |
---|
Kinase | RBC | Metz |
---|
eEF2K | - | - |